Predpokladaný rast EPS Q/Q spoločnosti Compu Medical SE
Aká je hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Compu Medical SE?
Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti CompuGroup Medical SE je 20.00%
Aká je definícia metriky Predpokladaný rast EPS Q/Q?
Očakávaný rast EPS (Estimated quarterly EPS growth rate) z roka na rok je predpokladaný rast EPS spoločnosti za ďaľší kvartál v porovnaní s výsledkami z minulého kvartálu.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Predpokladaný rast EPS Q/Q spoločností v sektore Health Care sektor na XETRA v porovnaní so spoločnosťou Compu Medical SE
Čomu sa venuje spoločnosť Compu Medical SE?
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
Firmy s metrikou predpokladaný rast eps q/q podobnou spoločnosti Compu Medical SE
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Shree Cement je 19.67%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Finning International je 19.67%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Airbnb je 19.67%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Alamo je 19.75%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Crown Castle Inc je 19.75%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti ExlService Inc je 19.83%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Compu Medical SE je 20.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Honeywell International Inc je 20.10%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Ramkrishna Forgings je 20.11%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti LogMeIn je 20.14%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti NetEase je 20.14%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Parag Milk Foods je 20.20%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti TCR2 Therapeutics je 20.29%